These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6718327)

  • 1. Predicting colon cancer screening behavior from health beliefs.
    Macrae FA; Hill DJ; St John DJ; Ambikapathy A; Garner JF
    Prev Med; 1984 Jan; 13(1):115-26. PubMed ID: 6718327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.
    Macrae FA; St John DJ; Ambikapathy A; Sharpe K; Garner JF
    Med J Aust; 1986 Jun; 144(12):621-3. PubMed ID: 3713601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Predicting Fecal Occult Blood Testing among Residents of Bushehr, Iran, Based on the Health Belief Model.
    Ghobadi Dashdebi K; Noroozi A; Tahmasebi R
    Asian Pac J Cancer Prev; 2016; 17(S3):17-22. PubMed ID: 27165201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient compliance with screening for fecal occult blood in family practice.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    CMAJ; 1987 Aug; 137(3):195-8. PubMed ID: 3607662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health belief and compliance with screening for fecal occult blood.
    Hoogewerf PE; Hislop TG; Morrison BJ; Burns SD; Sizto R
    Soc Sci Med; 1990; 30(6):721-6. PubMed ID: 2315741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing compliance with hemoccult screening for colon cancer in clinical practice.
    Thompson RS; Michnich ME; Gray J; Friedlander L; Gilson B
    Med Care; 1986 Oct; 24(10):904-14. PubMed ID: 3762240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colonic and rectal cancer screening using fecal occult blood analysis (our experience)].
    Trignano M; Uzzau A; Nonnis R; Terrosu G; Noce L; Farris A
    Chir Ital; 1986 Oct; 38(5):511-8. PubMed ID: 3815641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited.
    Hunter W; Farmer A; Mant D; Verne J; Northover J; Fitzpatrick R
    Fam Pract; 1991 Dec; 8(4):367-72. PubMed ID: 1800202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France).
    Launoy G; Veret JL; Richir B; Reaud JM; Ollivier V; Valla A; Gignoux M
    Eur J Cancer Prev; 1993 May; 2(3):229-32. PubMed ID: 8490541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial.
    Hardcastle JD; Armitage NC; Chamberlain J; Amar SS; James PD; Balfour TW
    Cancer; 1986 Jul; 58(2):397-403. PubMed ID: 3719535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation in faecal occult blood screening for colorectal cancer.
    Dent OF; Bartrop R; Goulston KJ; Chapuis PH
    Soc Sci Med; 1983; 17(1):17-23. PubMed ID: 6844949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.
    Kewenter J; Björk S; Haglind E; Smith L; Svanvik J; Ahrén C
    Cancer; 1988 Aug; 62(3):645-51. PubMed ID: 3292038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with fecal occult blood test screening among low-income medical outpatients: a randomized controlled trial using a videotaped intervention.
    Friedman LC; Everett TE; Peterson L; Ogbonnaya KI; Mendizabal V
    J Cancer Educ; 2001; 16(2):85-8. PubMed ID: 11440068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in fecal occult blood screening: a critical review.
    Blalock SJ; DeVellis BM; Sandler RS
    Prev Med; 1987 Jan; 16(1):9-18. PubMed ID: 3547387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stool occult blood screening for colorectal cancer.
    Frame PS; Kowulich BA
    J Fam Pract; 1982 Dec; 15(6):1071-5. PubMed ID: 7142926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer.
    Songster CL; Barrows GH; Jarrett DD
    Cancer; 1980 Mar; 45(5 Suppl):1099-102. PubMed ID: 6965607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.